Genome Editor: GFP-NLS
Summary
| SCGE ID | 11000000107 |
| Symbol | GFP-NLS |
| Description | Nuclear targeted GFP |
| Type | Reporter |
| Subtype | fluorescent protein |
| Alias | GFP-NLS (Feldan Therapeutics) |
| Activity | Fluorescence |
| Substrate | N/A |
| PAM | not applicable |
| Fusion | NLS |
| Source | Expressed From (Escherichia coli BL21DE3) |
Protein Sequence
MHHHHHHGGGGSGGGGSGGASTGTGIRMVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTG LPVPWPTLVTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFK DGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDP EKRDHMVLLEFVTAAGITLGMDELYKGGSGGGSGGGSGWIRASSGGRSSDDEATADSQHAAPPKKKRKVGGSGGGSGGG GGGRGTEIS |
Associated Publications |
| Publication Title |
|---|
| Engineered amphiphilic peptides enable delivery of proteins and CRISPR-associated nucleases to airway epithelia. NCBI |
Projects & Experiments
This Genome Editor: GFP-NLS is being used ...| Project | Initiative | Contact PI | |
|---|---|---|---|
| Delivery Systems |
Paul B McCray, Jr, MD
(University of Iowa) |
|